
Formanden har ordet: Godt gået Orphazyme! 29 November 2017
For knap to uger siden lykkedes det Orphazyme at gå på Børsen i København! Selskabet solgte 7,5 mio.... Read more

For knap to uger siden lykkedes det Orphazyme at gå på Børsen i København! Selskabet solgte 7,5 mio.... Read more

Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, today published an offering... Read more

Det danske biotekselskab MonTa Biosciences har netop tegnet en licensaftale med UC San Diego Universitet... Read more

Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, announces its intention to... Read more

Y-mAbs Therapeutics, Inc. closes $50 million in a private placement led by HBM Healthcare Investments... Read more

For nogle uger siden præsenterede regeringen sit erhvervs- og iværksætterudspil med 22 initiativer... Read more

Oral presentation of efficacy and safety data of Sym004 in refractory metastatic colorectal cancer Symphogen... Read more

Pan-Nordic mentor network NOME provides Nordic life science start-ups with the opportunity to present... Read more

Interesting EU project PERMIDES provides innovation vouchers for biopharma SMEs valued up to 60,000... Read more